MDisrupt’s central objective is to bridge the gap between the tech and medical worlds. In Silicon Valley a lot of smart technologists try to take on the inefficiencies of the health-care system without understanding the...
Filters
Launched just about a month ago, the health-tech consulting venture bills itself as as the world’s first “medical diligence company.” A seasoned executive in the health-tech sector, Gadelrab brings the business chops to complement Hagenkord’s experience as a pathologist and chief medical officer at multiple firms. Together, they claim decades of experience in the field, where they’ve witnessed one aspiring health-tech startup after another crash and burn.
Two executives have launched a new Silicon Valley firm, MDisrupt, designed to assess the medical claims made by health tech startups to help investors to separate the wheat from chaff and guide startups seeking to commercialize products.
The San Francisco-based social media platform is being increasingly used by the startup community to connect founders with top-tier investors. Veteran health care executive Ruby Gadelrab, CEO of MDisrupt, shares the one thing you must never do on the app however.
Welcome to the a voice-only app where users chat and debate on topics ranging from politics, business, tech, professional networking, sports, music, religion, and, business opportunities for digital health innovators.
Digital Health companies often face a struggle knowing where to begin on the road to regulatory approval. Issues such as conducting clinical validation studies and finding the right regulatory experts to assist in their journey can all present major hurdles. These difficulties prompted Ruby Gadelrab to create MDisrupt, a digital health intelligence company…
“Before making a sizable investment, it’s not uncommon for investors to conduct legal diligence, financial diligence and technical diligence in a healthtech startup. They rarely do the detailed medical diligence, and we believe that for a health product this should be a routine part of the diligence process,” says Chief Executive Officer and co-founder Ruby Gadelrab. “MDisrupt helps healthtech startups and their investors spot avoidable and costly mistakes early on, and get potentially impactful products to patients faster and more responsibly.”
You’ve got bold ambitions; we’ve got the network of expertise to get you there. Connect with elite healthcare experts who align with your mission and get your product to market—easily and with expertise.